Skip to content
← Full study record

NCT02196168 · MORE INFO

Limitations, agreements, and source contact

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · Source last updated 2017-05-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
Winquist@lhsc.on.ca
organization
London Health Sciences centre
phone
519-685-8500
title
Dr.Eric Winquist
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
Winquist@lhsc.on.ca
organization
London Health Sciences centre
phone
519-685-8500
title
Dr.Eric Winquist

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice